التفاصيل البيبلوغرافية
| العنوان: |
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial |
| المؤلفون: |
Shu, Catherine A, Gainor, Justin F, Awad, Mark M, Chiuzan, Codruta, Grigg, Claud M, Pabani, Aliyah, Garofano, Robert F, Stoopler, Mark B, Cheng, Simon K, White, Abby, Lanuti, Michael, D'Ovidio, Frank, Bacchetta, Matthew, Sonett, Joshua R, Saqi, Anjali, Rizvi, Naiyer A |
| المساهمون: |
Genentech, Gilead Sciences, AstraZeneca |
| المصدر: |
The Lancet Oncology ; volume 21, issue 6, page 786-795 ; ISSN 1470-2045 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2020 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/s1470-2045(20)30140-6 |
| الإتاحة: |
https://doi.org/10.1016/s1470-2045Test(20)30140-6
https://api.elsevier.com/content/article/PII:S1470204520301406?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1470204520301406?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
| رقم الانضمام: |
edsbas.2D44D7AD |
| قاعدة البيانات: |
BASE |
